Skip to main content
. 2017 Apr 27;8(30):49217–49223. doi: 10.18632/oncotarget.17455

Table 2. Levels of ESM-1 in MPE and association with the clinicopathological factors of NSCLC patients.

Clinical variables Number ESM-1(ng/ml) P-value
Age (years) 0.563
 ≥ 65 23 54.93 ± 8.12
 < 65 47 49.33 ± 5.46
Gender 0.930
 Male 40 50.82 ± 5.53
 Female 30 51.63 ± 7.61
Histological type 0.756
 Adenocarcinoma 53 51.97 ± 5.36
Squamous cell carcinoma 17 48.6 7 ± 8.30
Performance Status 0.515
 0 to 1 35 48.20 ± 6.20
 2 to 4 35 54.14 ± 6.59
Smoking status 0.138
 Nonsmoker 36 44.65 ± 6.00
 Smoker 34 58.07 ± 6.65
Tumor size (cm) 0.218
 ≤ 5 41 46.47 ± 5.17
 > 5 29 57.82 ± 8.01
Distant metastasis 0.020a
 Absent 31 39.18 ± 5.34
 Present 39 60.16 ± 6.49

aSignificant difference.